Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aripiprazole versus risperidone for methamphetamine-induced psychosis
IRCT20220103053615N1Phase 3Completed
- Sponsor
- University of Social Welfare and Rehabilitation Sciences
- Start
- Apr 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, double-blind trial of aripiprazole and risperidone (2 arms), sponsored by University of Social Welfare and Rehabilitation Sciences. Primary endpoint: Positive and Negative Syndrome Scale score. Started Apr 2022; status: completed.
02
Drugs
aripiprazolerisperidone
Beyond the preview
Go deeper on IRCT20220103053615N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20220103053615N1.